Join Advocacy Efforts
Urge Your Representative to Join the Pediatric Cancer Caucus
Recently, Rep. Joseph Sestak (D-PA) announced the formation of a bipartisan Pediatric Cancer Caucus, which he will chair, to provide a voice for children in this country who are suffering from cancer. The caucus is still being formed and looking for members. If your representative has been a champion of cancer causes, please urge them to join the Pediatric Cancer Caucus.
Act Now! - Urge Pennsylvania House of Representatives to Co-Sponsor Access to Cancer Clinical Trials Legislation
Pennsylvania state Rep. Anthony DeLuca is seeking support from his colleagues for legislation (HB 85) that would require insurance companies to cover “routine care costs” for cancer patients enrolled in a clinical trial. These are the same costs that are covered by insurance for a patient taking standard therapy. Please, take a moment to contact your elected state representatives and ask them to co-sponsor HB 85 today!
Act Now! - Urge Pennsylvania Senate to Co-Sponsor Access to Cancer Clinical Trials Legislation
Pennsylvania state Sen. Michael O’Pake has circulated a memo seeking support from his colleagues for legislation that would require insurance companies to cover “routine care costs” for cancer patients enrolled in a clinical trial. These are the same costs that are covered by insurance for a patient taking standard therapy. Contact your state senators and ask them to co-sponsor Sen. O’Pake’s legislation now!
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
